Atlas Trials

Study Evaluating Single Ascending Doses of AAB-001 Vaccine SAD Japanese Patients With Alzheimers Disease

Clinical trial NCT00397891 · COMPLETED

Trial details

NCT number
NCT00397891
Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2006-10-01
Primary completion
2010-02-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.